Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Erasca Inc (ERAS)

Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Erasca Inc 3115 MERRYFIELD ROW SUITE 300 SAN DIEGO CA 92121 USA

www.erasca.com Employees: 103 P: 858-465-6511

Sector:

Medical

Description:

Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 3,479,758
Enterprise Value, $K 3,412,018
Shares Outstanding, K 309,587
Float, K 265,006
% Float 85.60%
Short Interest, K 26,637
Short Float 8.60%
Days to Cover 2.20
Short Volume Ratio 0.49
% of Insider Shareholders 14.40%
% of Institutional Shareholders 67.78%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -161,650 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,610 K
EBIT, $ -144,020 K
EBITDA, $ -149,810 K

Growth:

1-Year Return 531.46%
3-Year Return 188.21%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/12/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 8.33%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ERAS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -33.10%
Return-on-Assets % -27.76%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.65
Book Value/Share 1.23
Interest Coverage -2.87
60-Month Beta 1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar